Malignant Neoplasm of the Oral Cavity, Oropharynx and Hypopharynx B034
Current RMA Instruments
| Reasonable Hypothesis | 65 of 2021 |
| Balance of Probabilities | 66 of 2021 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 140.3,140.4,140.5,141,143,144,145,146,148
- ICD-10-AM Codes: C00-C06, C09-C10, C12-C13
Brief description
This SOP covers cancers of the mouth cavity (oral cavity), the back of the mouth cavity (oropharynx) and the area of the throat immediately below that (hypopharynx).
Confirming the diagnosis
Evidence on the histological type of tumour and the specific site of the tumour will be required, either from a biopsy or a surgical specimen. There are a number of cancer types involving these sites that are excluded from this SOP, including minor salivary gland cancers, which occur in the oral cavity but which are covered by a separate SOP. See excluded conditions list below.
The appropriate medical/dental specialist is an Oral surgeon or an Ear, Nose and Throat surgeon.
Sites covered by SOP
- alveolar ridge
- buccal (cheek) mucosa
- floor of mouth
- gingiva
- gums
- hard palate mucosa
- hypopharynx
- lingual tonsil coverings
- lips (mucosa of inside only)
- oropharynx
- palatine or faucial tonsil coverings
- post cricoid fossa
- pyriform fossa
- soft palate mucosa
- tongue mucosa
- tonsil fossa
- vallecula
Conditions excluded from SOP
- adenoid cystic carcinoma in the oral cavity (= minor salivary gland cancer)* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the larynx*
- malignant neoplasm of the lip epithelium* - non-melanotic malignant neoplasm of the skin SOP
- malignant neoplasm of the nasopharynx*
- malignant neoplasm of the minor salivary glands* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the oesophagus*
- malignant neoplasm of the salivary glands* (parotid, sublingual, submandibular)
- Hodgkin’s lymphoma* of the oral cavity, oropharynx or hypopharynx
- non-Hodgkin lymphoma* of the oral cavity, oropharynx or hypopharynx
- soft tissue sarcoma* of the oral cavity, oropharynx or hypopharynx
- carcinoid of the oral cavity, oropharynx or hypopharynx#
- secondary/metastatic cancer/carcinoma involving the oral cavity or hypopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
These conditions may present with a range of symptoms, such as non-healing mouth ulcers, pain, bleeding and difficulty swallowing. On confirmation of diagnosis it may be possible to back-date clinical onset based on when relevant symptoms first began.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management generally involves surgery or radiotherapy +/- chemotherapy. Effectiveness of treatment varies with the type and stage or disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/m/malignant-neoplasm-oral-cavity-oropharynx-and-hypopharynx-b034-140314041405141
Rulebase for malignant neoplasm of the oral cavity and oropharynx and hypopharynx
<h5>Current RMA Instruments</h5><table border="1" cellpadding="1" cellspacing="1"><tbody><tr><td><address><a href="http://www.rma.gov.au/assets/SOP/2021/eee3a61b78/065.pdf" target="_blank">Reasonable Hypothesis</a></address></td><td>65 of 2021</td></tr><tr><td><address><a href="http://www.rma.gov.au/assets/SOP/2021/3f14787492/066.pdf" target="_blank">Balance of Probabilities</a></address></td><td>66 of 2021</td></tr></tbody></table><h5>Changes from previous Instruments</h5><p><drupal-media data-entity-type="media" data-entity-uuid="c79ea6b1-75ac-4da8-ba2c-7e3951b5f183" data-view-mode="wysiwyg"></drupal-media></p><h5>ICD Coding</h5><ul><li>ICD-9-CM Codes: 140.3,140.4,140.5,141,143,144,145,146,148</li><li>ICD-10-AM Codes: C00-C06, C09-C10, C12-C13</li></ul><h5>Brief description</h5><p>This SOP covers cancers of the mouth cavity (oral cavity), the back of the mouth cavity (oropharynx) and the area of the throat immediately below that (hypopharynx).</p><h5>Confirming the diagnosis</h5><p>Evidence on the histological type of tumour and the specific site of the tumour will be required, either from a biopsy or a surgical specimen. There are a number of cancer types involving these sites that are excluded from this SOP, including minor salivary gland cancers, which occur in the oral cavity but which are covered by a separate SOP. See excluded conditions list below.</p><p>The appropriate medical/dental specialist is an Oral surgeon or an Ear, Nose and Throat surgeon.</p><h5><b>Sites covered by SOP</b></h5><ul><li>alveolar ridge</li><li>buccal (cheek) mucosa</li><li>floor of mouth</li><li>gingiva</li><li>gums</li><li>hard palate mucosa</li><li>hypopharynx</li><li>lingual tonsil coverings</li><li>lips (mucosa of inside only)</li><li>oropharynx</li><li>palatine or faucial tonsil coverings</li><li>post cricoid fossa</li><li>pyriform fossa</li><li>soft palate mucosa</li><li>tongue mucosa</li><li>tonsil fossa</li><li>vallecula</li></ul><h5><b>Conditions excluded from SOP</b></h5><ul><li>adenoid cystic carcinoma in the oral cavity (= minor salivary gland cancer)* - malignant neoplasm of the salivary gland SOP</li><li>malignant neoplasm of the larynx*</li><li>malignant neoplasm of the lip epithelium* - non-melanotic malignant neoplasm of the skin SOP</li><li>malignant neoplasm of the nasopharynx*</li><li>malignant neoplasm of the minor salivary glands* - malignant neoplasm of the salivary gland SOP</li><li>malignant neoplasm of the oesophagus*</li><li>malignant neoplasm of the salivary glands* (parotid, sublingual, submandibular)</li><li>Hodgkin’s lymphoma*<em> </em>of the oral cavity, oropharynx or hypopharynx</li><li>non-Hodgkin lymphoma<em>* </em>of the oral cavity, oropharynx or hypopharynx</li><li>soft tissue sarcoma<em>* </em>of the oral cavity, oropharynx or hypopharynx</li><li>carcinoid of the oral cavity, oropharynx or hypopharynx<span><sup>#</sup></span></li><li>secondary/metastatic cancer/carcinoma involving the oral cavity or hypopharynx (code to primary cancer site)</li></ul><p>* another SOP applies</p><p><sup><span># </span></sup>non-SOP condition</p><p> </p><h5><b>Clinical onset</b></h5><p>These conditions may present with a range of symptoms, such as non-healing mouth ulcers, pain, bleeding and difficulty swallowing. On confirmation of diagnosis it may be possible to back-date clinical onset based on when relevant symptoms first began.</p><h5>Clinical worsening</h5><p>The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management generally involves surgery or radiotherapy +/- chemotherapy. Effectiveness of treatment varies with the type and stage or disease.</p>
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/rulebase-malignant-neoplasm-oral-cavity-and-oropharynx-and-hypopharynx
A bone marrow transplant
Current RMA Instruments
| Reasonable Hypothesis | 65 of 2021 |
| Balance of Probabilities | 66 of 2021 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 140.3,140.4,140.5,141,143,144,145,146,148
- ICD-10-AM Codes: C00-C06, C09-C10, C12-C13
Brief description
This SOP covers cancers of the mouth cavity (oral cavity), the back of the mouth cavity (oropharynx) and the area of the throat immediately below that (hypopharynx).
Confirming the diagnosis
Evidence on the histological type of tumour and the specific site of the tumour will be required, either from a biopsy or a surgical specimen. There are a number of cancer types involving these sites that are excluded from this SOP, including minor salivary gland cancers, which occur in the oral cavity but which are covered by a separate SOP. See excluded conditions list below.
The appropriate medical/dental specialist is an Oral surgeon or an Ear, Nose and Throat surgeon.
Sites covered by SOP
- alveolar ridge
- buccal (cheek) mucosa
- floor of mouth
- gingiva
- gums
- hard palate mucosa
- hypopharynx
- lingual tonsil coverings
- lips (mucosa of inside only)
- oropharynx
- palatine or faucial tonsil coverings
- post cricoid fossa
- pyriform fossa
- soft palate mucosa
- tongue mucosa
- tonsil fossa
- vallecula
Conditions excluded from SOP
- adenoid cystic carcinoma in the oral cavity (= minor salivary gland cancer)* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the larynx*
- malignant neoplasm of the lip epithelium* - non-melanotic malignant neoplasm of the skin SOP
- malignant neoplasm of the nasopharynx*
- malignant neoplasm of the minor salivary glands* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the oesophagus*
- malignant neoplasm of the salivary glands* (parotid, sublingual, submandibular)
- Hodgkin’s lymphoma* of the oral cavity, oropharynx or hypopharynx
- non-Hodgkin lymphoma* of the oral cavity, oropharynx or hypopharynx
- soft tissue sarcoma* of the oral cavity, oropharynx or hypopharynx
- carcinoid of the oral cavity, oropharynx or hypopharynx#
- secondary/metastatic cancer/carcinoma involving the oral cavity or hypopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
These conditions may present with a range of symptoms, such as non-healing mouth ulcers, pain, bleeding and difficulty swallowing. On confirmation of diagnosis it may be possible to back-date clinical onset based on when relevant symptoms first began.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management generally involves surgery or radiotherapy +/- chemotherapy. Effectiveness of treatment varies with the type and stage or disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oral-cavity-oropharynx-and-hypopharynx-b034-140314041405141/rulebase-malignant-neoplasm-oral-cavity-and-oropharynx-and-hypopharynx/bone-marrow-transplant
Alcohol consumption
Current RMA Instruments
| Reasonable Hypothesis | 65 of 2021 |
| Balance of Probabilities | 66 of 2021 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 140.3,140.4,140.5,141,143,144,145,146,148
- ICD-10-AM Codes: C00-C06, C09-C10, C12-C13
Brief description
This SOP covers cancers of the mouth cavity (oral cavity), the back of the mouth cavity (oropharynx) and the area of the throat immediately below that (hypopharynx).
Confirming the diagnosis
Evidence on the histological type of tumour and the specific site of the tumour will be required, either from a biopsy or a surgical specimen. There are a number of cancer types involving these sites that are excluded from this SOP, including minor salivary gland cancers, which occur in the oral cavity but which are covered by a separate SOP. See excluded conditions list below.
The appropriate medical/dental specialist is an Oral surgeon or an Ear, Nose and Throat surgeon.
Sites covered by SOP
- alveolar ridge
- buccal (cheek) mucosa
- floor of mouth
- gingiva
- gums
- hard palate mucosa
- hypopharynx
- lingual tonsil coverings
- lips (mucosa of inside only)
- oropharynx
- palatine or faucial tonsil coverings
- post cricoid fossa
- pyriform fossa
- soft palate mucosa
- tongue mucosa
- tonsil fossa
- vallecula
Conditions excluded from SOP
- adenoid cystic carcinoma in the oral cavity (= minor salivary gland cancer)* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the larynx*
- malignant neoplasm of the lip epithelium* - non-melanotic malignant neoplasm of the skin SOP
- malignant neoplasm of the nasopharynx*
- malignant neoplasm of the minor salivary glands* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the oesophagus*
- malignant neoplasm of the salivary glands* (parotid, sublingual, submandibular)
- Hodgkin’s lymphoma* of the oral cavity, oropharynx or hypopharynx
- non-Hodgkin lymphoma* of the oral cavity, oropharynx or hypopharynx
- soft tissue sarcoma* of the oral cavity, oropharynx or hypopharynx
- carcinoid of the oral cavity, oropharynx or hypopharynx#
- secondary/metastatic cancer/carcinoma involving the oral cavity or hypopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
These conditions may present with a range of symptoms, such as non-healing mouth ulcers, pain, bleeding and difficulty swallowing. On confirmation of diagnosis it may be possible to back-date clinical onset based on when relevant symptoms first began.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management generally involves surgery or radiotherapy +/- chemotherapy. Effectiveness of treatment varies with the type and stage or disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oral-cavity-oropharynx-and-hypopharynx-b034-140314041405141/rulebase-malignant-neoplasm-oral-cavity-and-oropharynx-and-hypopharynx/alcohol-consumption
Chewing betel quid or areca nut
Current RMA Instruments
| Reasonable Hypothesis | 65 of 2021 |
| Balance of Probabilities | 66 of 2021 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 140.3,140.4,140.5,141,143,144,145,146,148
- ICD-10-AM Codes: C00-C06, C09-C10, C12-C13
Brief description
This SOP covers cancers of the mouth cavity (oral cavity), the back of the mouth cavity (oropharynx) and the area of the throat immediately below that (hypopharynx).
Confirming the diagnosis
Evidence on the histological type of tumour and the specific site of the tumour will be required, either from a biopsy or a surgical specimen. There are a number of cancer types involving these sites that are excluded from this SOP, including minor salivary gland cancers, which occur in the oral cavity but which are covered by a separate SOP. See excluded conditions list below.
The appropriate medical/dental specialist is an Oral surgeon or an Ear, Nose and Throat surgeon.
Sites covered by SOP
- alveolar ridge
- buccal (cheek) mucosa
- floor of mouth
- gingiva
- gums
- hard palate mucosa
- hypopharynx
- lingual tonsil coverings
- lips (mucosa of inside only)
- oropharynx
- palatine or faucial tonsil coverings
- post cricoid fossa
- pyriform fossa
- soft palate mucosa
- tongue mucosa
- tonsil fossa
- vallecula
Conditions excluded from SOP
- adenoid cystic carcinoma in the oral cavity (= minor salivary gland cancer)* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the larynx*
- malignant neoplasm of the lip epithelium* - non-melanotic malignant neoplasm of the skin SOP
- malignant neoplasm of the nasopharynx*
- malignant neoplasm of the minor salivary glands* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the oesophagus*
- malignant neoplasm of the salivary glands* (parotid, sublingual, submandibular)
- Hodgkin’s lymphoma* of the oral cavity, oropharynx or hypopharynx
- non-Hodgkin lymphoma* of the oral cavity, oropharynx or hypopharynx
- soft tissue sarcoma* of the oral cavity, oropharynx or hypopharynx
- carcinoid of the oral cavity, oropharynx or hypopharynx#
- secondary/metastatic cancer/carcinoma involving the oral cavity or hypopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
These conditions may present with a range of symptoms, such as non-healing mouth ulcers, pain, bleeding and difficulty swallowing. On confirmation of diagnosis it may be possible to back-date clinical onset based on when relevant symptoms first began.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management generally involves surgery or radiotherapy +/- chemotherapy. Effectiveness of treatment varies with the type and stage or disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oral-cavity-oropharynx-and-hypopharynx-b034-140314041405141/rulebase-malignant-neoplasm-oral-cavity-and-oropharynx-and-hypopharynx/chewing-betel-quid-or-areca-nut
Cigar smoking
Current RMA Instruments
| Reasonable Hypothesis | 65 of 2021 |
| Balance of Probabilities | 66 of 2021 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 140.3,140.4,140.5,141,143,144,145,146,148
- ICD-10-AM Codes: C00-C06, C09-C10, C12-C13
Brief description
This SOP covers cancers of the mouth cavity (oral cavity), the back of the mouth cavity (oropharynx) and the area of the throat immediately below that (hypopharynx).
Confirming the diagnosis
Evidence on the histological type of tumour and the specific site of the tumour will be required, either from a biopsy or a surgical specimen. There are a number of cancer types involving these sites that are excluded from this SOP, including minor salivary gland cancers, which occur in the oral cavity but which are covered by a separate SOP. See excluded conditions list below.
The appropriate medical/dental specialist is an Oral surgeon or an Ear, Nose and Throat surgeon.
Sites covered by SOP
- alveolar ridge
- buccal (cheek) mucosa
- floor of mouth
- gingiva
- gums
- hard palate mucosa
- hypopharynx
- lingual tonsil coverings
- lips (mucosa of inside only)
- oropharynx
- palatine or faucial tonsil coverings
- post cricoid fossa
- pyriform fossa
- soft palate mucosa
- tongue mucosa
- tonsil fossa
- vallecula
Conditions excluded from SOP
- adenoid cystic carcinoma in the oral cavity (= minor salivary gland cancer)* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the larynx*
- malignant neoplasm of the lip epithelium* - non-melanotic malignant neoplasm of the skin SOP
- malignant neoplasm of the nasopharynx*
- malignant neoplasm of the minor salivary glands* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the oesophagus*
- malignant neoplasm of the salivary glands* (parotid, sublingual, submandibular)
- Hodgkin’s lymphoma* of the oral cavity, oropharynx or hypopharynx
- non-Hodgkin lymphoma* of the oral cavity, oropharynx or hypopharynx
- soft tissue sarcoma* of the oral cavity, oropharynx or hypopharynx
- carcinoid of the oral cavity, oropharynx or hypopharynx#
- secondary/metastatic cancer/carcinoma involving the oral cavity or hypopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
These conditions may present with a range of symptoms, such as non-healing mouth ulcers, pain, bleeding and difficulty swallowing. On confirmation of diagnosis it may be possible to back-date clinical onset based on when relevant symptoms first began.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management generally involves surgery or radiotherapy +/- chemotherapy. Effectiveness of treatment varies with the type and stage or disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oral-cavity-oropharynx-and-hypopharynx-b034-140314041405141/rulebase-malignant-neoplasm-oral-cavity-and-oropharynx-and-hypopharynx/cigar-smoking
Cigarette smoking
Current RMA Instruments
| Reasonable Hypothesis | 65 of 2021 |
| Balance of Probabilities | 66 of 2021 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 140.3,140.4,140.5,141,143,144,145,146,148
- ICD-10-AM Codes: C00-C06, C09-C10, C12-C13
Brief description
This SOP covers cancers of the mouth cavity (oral cavity), the back of the mouth cavity (oropharynx) and the area of the throat immediately below that (hypopharynx).
Confirming the diagnosis
Evidence on the histological type of tumour and the specific site of the tumour will be required, either from a biopsy or a surgical specimen. There are a number of cancer types involving these sites that are excluded from this SOP, including minor salivary gland cancers, which occur in the oral cavity but which are covered by a separate SOP. See excluded conditions list below.
The appropriate medical/dental specialist is an Oral surgeon or an Ear, Nose and Throat surgeon.
Sites covered by SOP
- alveolar ridge
- buccal (cheek) mucosa
- floor of mouth
- gingiva
- gums
- hard palate mucosa
- hypopharynx
- lingual tonsil coverings
- lips (mucosa of inside only)
- oropharynx
- palatine or faucial tonsil coverings
- post cricoid fossa
- pyriform fossa
- soft palate mucosa
- tongue mucosa
- tonsil fossa
- vallecula
Conditions excluded from SOP
- adenoid cystic carcinoma in the oral cavity (= minor salivary gland cancer)* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the larynx*
- malignant neoplasm of the lip epithelium* - non-melanotic malignant neoplasm of the skin SOP
- malignant neoplasm of the nasopharynx*
- malignant neoplasm of the minor salivary glands* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the oesophagus*
- malignant neoplasm of the salivary glands* (parotid, sublingual, submandibular)
- Hodgkin’s lymphoma* of the oral cavity, oropharynx or hypopharynx
- non-Hodgkin lymphoma* of the oral cavity, oropharynx or hypopharynx
- soft tissue sarcoma* of the oral cavity, oropharynx or hypopharynx
- carcinoid of the oral cavity, oropharynx or hypopharynx#
- secondary/metastatic cancer/carcinoma involving the oral cavity or hypopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
These conditions may present with a range of symptoms, such as non-healing mouth ulcers, pain, bleeding and difficulty swallowing. On confirmation of diagnosis it may be possible to back-date clinical onset based on when relevant symptoms first began.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management generally involves surgery or radiotherapy +/- chemotherapy. Effectiveness of treatment varies with the type and stage or disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oral-cavity-oropharynx-and-hypopharynx-b034-140314041405141/rulebase-malignant-neoplasm-oral-cavity-and-oropharynx-and-hypopharynx/cigarette-smoking
Drinking maté
Current RMA Instruments
| Reasonable Hypothesis | 65 of 2021 |
| Balance of Probabilities | 66 of 2021 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 140.3,140.4,140.5,141,143,144,145,146,148
- ICD-10-AM Codes: C00-C06, C09-C10, C12-C13
Brief description
This SOP covers cancers of the mouth cavity (oral cavity), the back of the mouth cavity (oropharynx) and the area of the throat immediately below that (hypopharynx).
Confirming the diagnosis
Evidence on the histological type of tumour and the specific site of the tumour will be required, either from a biopsy or a surgical specimen. There are a number of cancer types involving these sites that are excluded from this SOP, including minor salivary gland cancers, which occur in the oral cavity but which are covered by a separate SOP. See excluded conditions list below.
The appropriate medical/dental specialist is an Oral surgeon or an Ear, Nose and Throat surgeon.
Sites covered by SOP
- alveolar ridge
- buccal (cheek) mucosa
- floor of mouth
- gingiva
- gums
- hard palate mucosa
- hypopharynx
- lingual tonsil coverings
- lips (mucosa of inside only)
- oropharynx
- palatine or faucial tonsil coverings
- post cricoid fossa
- pyriform fossa
- soft palate mucosa
- tongue mucosa
- tonsil fossa
- vallecula
Conditions excluded from SOP
- adenoid cystic carcinoma in the oral cavity (= minor salivary gland cancer)* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the larynx*
- malignant neoplasm of the lip epithelium* - non-melanotic malignant neoplasm of the skin SOP
- malignant neoplasm of the nasopharynx*
- malignant neoplasm of the minor salivary glands* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the oesophagus*
- malignant neoplasm of the salivary glands* (parotid, sublingual, submandibular)
- Hodgkin’s lymphoma* of the oral cavity, oropharynx or hypopharynx
- non-Hodgkin lymphoma* of the oral cavity, oropharynx or hypopharynx
- soft tissue sarcoma* of the oral cavity, oropharynx or hypopharynx
- carcinoid of the oral cavity, oropharynx or hypopharynx#
- secondary/metastatic cancer/carcinoma involving the oral cavity or hypopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
These conditions may present with a range of symptoms, such as non-healing mouth ulcers, pain, bleeding and difficulty swallowing. On confirmation of diagnosis it may be possible to back-date clinical onset based on when relevant symptoms first began.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management generally involves surgery or radiotherapy +/- chemotherapy. Effectiveness of treatment varies with the type and stage or disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oral-cavity-oropharynx-and-hypopharynx-b034-140314041405141/rulebase-malignant-neoplasm-oral-cavity-and-oropharynx-and-hypopharynx/drinking-mat
Human papilloma virus infection
Current RMA Instruments
| Reasonable Hypothesis | 65 of 2021 |
| Balance of Probabilities | 66 of 2021 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 140.3,140.4,140.5,141,143,144,145,146,148
- ICD-10-AM Codes: C00-C06, C09-C10, C12-C13
Brief description
This SOP covers cancers of the mouth cavity (oral cavity), the back of the mouth cavity (oropharynx) and the area of the throat immediately below that (hypopharynx).
Confirming the diagnosis
Evidence on the histological type of tumour and the specific site of the tumour will be required, either from a biopsy or a surgical specimen. There are a number of cancer types involving these sites that are excluded from this SOP, including minor salivary gland cancers, which occur in the oral cavity but which are covered by a separate SOP. See excluded conditions list below.
The appropriate medical/dental specialist is an Oral surgeon or an Ear, Nose and Throat surgeon.
Sites covered by SOP
- alveolar ridge
- buccal (cheek) mucosa
- floor of mouth
- gingiva
- gums
- hard palate mucosa
- hypopharynx
- lingual tonsil coverings
- lips (mucosa of inside only)
- oropharynx
- palatine or faucial tonsil coverings
- post cricoid fossa
- pyriform fossa
- soft palate mucosa
- tongue mucosa
- tonsil fossa
- vallecula
Conditions excluded from SOP
- adenoid cystic carcinoma in the oral cavity (= minor salivary gland cancer)* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the larynx*
- malignant neoplasm of the lip epithelium* - non-melanotic malignant neoplasm of the skin SOP
- malignant neoplasm of the nasopharynx*
- malignant neoplasm of the minor salivary glands* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the oesophagus*
- malignant neoplasm of the salivary glands* (parotid, sublingual, submandibular)
- Hodgkin’s lymphoma* of the oral cavity, oropharynx or hypopharynx
- non-Hodgkin lymphoma* of the oral cavity, oropharynx or hypopharynx
- soft tissue sarcoma* of the oral cavity, oropharynx or hypopharynx
- carcinoid of the oral cavity, oropharynx or hypopharynx#
- secondary/metastatic cancer/carcinoma involving the oral cavity or hypopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
These conditions may present with a range of symptoms, such as non-healing mouth ulcers, pain, bleeding and difficulty swallowing. On confirmation of diagnosis it may be possible to back-date clinical onset based on when relevant symptoms first began.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management generally involves surgery or radiotherapy +/- chemotherapy. Effectiveness of treatment varies with the type and stage or disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oral-cavity-oropharynx-and-hypopharynx-b034-140314041405141/rulebase-malignant-neoplasm-oral-cavity-and-oropharynx-and-hypopharynx/human-papilloma-virus-infection
Mustard gas
Current RMA Instruments
| Reasonable Hypothesis | 65 of 2021 |
| Balance of Probabilities | 66 of 2021 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 140.3,140.4,140.5,141,143,144,145,146,148
- ICD-10-AM Codes: C00-C06, C09-C10, C12-C13
Brief description
This SOP covers cancers of the mouth cavity (oral cavity), the back of the mouth cavity (oropharynx) and the area of the throat immediately below that (hypopharynx).
Confirming the diagnosis
Evidence on the histological type of tumour and the specific site of the tumour will be required, either from a biopsy or a surgical specimen. There are a number of cancer types involving these sites that are excluded from this SOP, including minor salivary gland cancers, which occur in the oral cavity but which are covered by a separate SOP. See excluded conditions list below.
The appropriate medical/dental specialist is an Oral surgeon or an Ear, Nose and Throat surgeon.
Sites covered by SOP
- alveolar ridge
- buccal (cheek) mucosa
- floor of mouth
- gingiva
- gums
- hard palate mucosa
- hypopharynx
- lingual tonsil coverings
- lips (mucosa of inside only)
- oropharynx
- palatine or faucial tonsil coverings
- post cricoid fossa
- pyriform fossa
- soft palate mucosa
- tongue mucosa
- tonsil fossa
- vallecula
Conditions excluded from SOP
- adenoid cystic carcinoma in the oral cavity (= minor salivary gland cancer)* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the larynx*
- malignant neoplasm of the lip epithelium* - non-melanotic malignant neoplasm of the skin SOP
- malignant neoplasm of the nasopharynx*
- malignant neoplasm of the minor salivary glands* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the oesophagus*
- malignant neoplasm of the salivary glands* (parotid, sublingual, submandibular)
- Hodgkin’s lymphoma* of the oral cavity, oropharynx or hypopharynx
- non-Hodgkin lymphoma* of the oral cavity, oropharynx or hypopharynx
- soft tissue sarcoma* of the oral cavity, oropharynx or hypopharynx
- carcinoid of the oral cavity, oropharynx or hypopharynx#
- secondary/metastatic cancer/carcinoma involving the oral cavity or hypopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
These conditions may present with a range of symptoms, such as non-healing mouth ulcers, pain, bleeding and difficulty swallowing. On confirmation of diagnosis it may be possible to back-date clinical onset based on when relevant symptoms first began.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management generally involves surgery or radiotherapy +/- chemotherapy. Effectiveness of treatment varies with the type and stage or disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oral-cavity-oropharynx-and-hypopharynx-b034-140314041405141/rulebase-malignant-neoplasm-oral-cavity-and-oropharynx-and-hypopharynx/mustard-gas
No appropriate clinical management for neoplasm of oral cavity or hypopharynx
Current RMA Instruments
| Reasonable Hypothesis | 65 of 2021 |
| Balance of Probabilities | 66 of 2021 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 140.3,140.4,140.5,141,143,144,145,146,148
- ICD-10-AM Codes: C00-C06, C09-C10, C12-C13
Brief description
This SOP covers cancers of the mouth cavity (oral cavity), the back of the mouth cavity (oropharynx) and the area of the throat immediately below that (hypopharynx).
Confirming the diagnosis
Evidence on the histological type of tumour and the specific site of the tumour will be required, either from a biopsy or a surgical specimen. There are a number of cancer types involving these sites that are excluded from this SOP, including minor salivary gland cancers, which occur in the oral cavity but which are covered by a separate SOP. See excluded conditions list below.
The appropriate medical/dental specialist is an Oral surgeon or an Ear, Nose and Throat surgeon.
Sites covered by SOP
- alveolar ridge
- buccal (cheek) mucosa
- floor of mouth
- gingiva
- gums
- hard palate mucosa
- hypopharynx
- lingual tonsil coverings
- lips (mucosa of inside only)
- oropharynx
- palatine or faucial tonsil coverings
- post cricoid fossa
- pyriform fossa
- soft palate mucosa
- tongue mucosa
- tonsil fossa
- vallecula
Conditions excluded from SOP
- adenoid cystic carcinoma in the oral cavity (= minor salivary gland cancer)* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the larynx*
- malignant neoplasm of the lip epithelium* - non-melanotic malignant neoplasm of the skin SOP
- malignant neoplasm of the nasopharynx*
- malignant neoplasm of the minor salivary glands* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the oesophagus*
- malignant neoplasm of the salivary glands* (parotid, sublingual, submandibular)
- Hodgkin’s lymphoma* of the oral cavity, oropharynx or hypopharynx
- non-Hodgkin lymphoma* of the oral cavity, oropharynx or hypopharynx
- soft tissue sarcoma* of the oral cavity, oropharynx or hypopharynx
- carcinoid of the oral cavity, oropharynx or hypopharynx#
- secondary/metastatic cancer/carcinoma involving the oral cavity or hypopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
These conditions may present with a range of symptoms, such as non-healing mouth ulcers, pain, bleeding and difficulty swallowing. On confirmation of diagnosis it may be possible to back-date clinical onset based on when relevant symptoms first began.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management generally involves surgery or radiotherapy +/- chemotherapy. Effectiveness of treatment varies with the type and stage or disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oral-cavity-oropharynx-and-hypopharynx-b034-140314041405141/rulebase-malignant-neoplasm-oral-cavity-and-oropharynx-and-hypopharynx/no-appropriate-clinical-management-neoplasm-oral
Oral leucoplakia
Current RMA Instruments
| Reasonable Hypothesis | 65 of 2021 |
| Balance of Probabilities | 66 of 2021 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 140.3,140.4,140.5,141,143,144,145,146,148
- ICD-10-AM Codes: C00-C06, C09-C10, C12-C13
Brief description
This SOP covers cancers of the mouth cavity (oral cavity), the back of the mouth cavity (oropharynx) and the area of the throat immediately below that (hypopharynx).
Confirming the diagnosis
Evidence on the histological type of tumour and the specific site of the tumour will be required, either from a biopsy or a surgical specimen. There are a number of cancer types involving these sites that are excluded from this SOP, including minor salivary gland cancers, which occur in the oral cavity but which are covered by a separate SOP. See excluded conditions list below.
The appropriate medical/dental specialist is an Oral surgeon or an Ear, Nose and Throat surgeon.
Sites covered by SOP
- alveolar ridge
- buccal (cheek) mucosa
- floor of mouth
- gingiva
- gums
- hard palate mucosa
- hypopharynx
- lingual tonsil coverings
- lips (mucosa of inside only)
- oropharynx
- palatine or faucial tonsil coverings
- post cricoid fossa
- pyriform fossa
- soft palate mucosa
- tongue mucosa
- tonsil fossa
- vallecula
Conditions excluded from SOP
- adenoid cystic carcinoma in the oral cavity (= minor salivary gland cancer)* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the larynx*
- malignant neoplasm of the lip epithelium* - non-melanotic malignant neoplasm of the skin SOP
- malignant neoplasm of the nasopharynx*
- malignant neoplasm of the minor salivary glands* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the oesophagus*
- malignant neoplasm of the salivary glands* (parotid, sublingual, submandibular)
- Hodgkin’s lymphoma* of the oral cavity, oropharynx or hypopharynx
- non-Hodgkin lymphoma* of the oral cavity, oropharynx or hypopharynx
- soft tissue sarcoma* of the oral cavity, oropharynx or hypopharynx
- carcinoid of the oral cavity, oropharynx or hypopharynx#
- secondary/metastatic cancer/carcinoma involving the oral cavity or hypopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
These conditions may present with a range of symptoms, such as non-healing mouth ulcers, pain, bleeding and difficulty swallowing. On confirmation of diagnosis it may be possible to back-date clinical onset based on when relevant symptoms first began.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management generally involves surgery or radiotherapy +/- chemotherapy. Effectiveness of treatment varies with the type and stage or disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oral-cavity-oropharynx-and-hypopharynx-b034-140314041405141/rulebase-malignant-neoplasm-oral-cavity-and-oropharynx-and-hypopharynx/oral-leucoplakia
Pipe smoking
Current RMA Instruments
| Reasonable Hypothesis | 65 of 2021 |
| Balance of Probabilities | 66 of 2021 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 140.3,140.4,140.5,141,143,144,145,146,148
- ICD-10-AM Codes: C00-C06, C09-C10, C12-C13
Brief description
This SOP covers cancers of the mouth cavity (oral cavity), the back of the mouth cavity (oropharynx) and the area of the throat immediately below that (hypopharynx).
Confirming the diagnosis
Evidence on the histological type of tumour and the specific site of the tumour will be required, either from a biopsy or a surgical specimen. There are a number of cancer types involving these sites that are excluded from this SOP, including minor salivary gland cancers, which occur in the oral cavity but which are covered by a separate SOP. See excluded conditions list below.
The appropriate medical/dental specialist is an Oral surgeon or an Ear, Nose and Throat surgeon.
Sites covered by SOP
- alveolar ridge
- buccal (cheek) mucosa
- floor of mouth
- gingiva
- gums
- hard palate mucosa
- hypopharynx
- lingual tonsil coverings
- lips (mucosa of inside only)
- oropharynx
- palatine or faucial tonsil coverings
- post cricoid fossa
- pyriform fossa
- soft palate mucosa
- tongue mucosa
- tonsil fossa
- vallecula
Conditions excluded from SOP
- adenoid cystic carcinoma in the oral cavity (= minor salivary gland cancer)* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the larynx*
- malignant neoplasm of the lip epithelium* - non-melanotic malignant neoplasm of the skin SOP
- malignant neoplasm of the nasopharynx*
- malignant neoplasm of the minor salivary glands* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the oesophagus*
- malignant neoplasm of the salivary glands* (parotid, sublingual, submandibular)
- Hodgkin’s lymphoma* of the oral cavity, oropharynx or hypopharynx
- non-Hodgkin lymphoma* of the oral cavity, oropharynx or hypopharynx
- soft tissue sarcoma* of the oral cavity, oropharynx or hypopharynx
- carcinoid of the oral cavity, oropharynx or hypopharynx#
- secondary/metastatic cancer/carcinoma involving the oral cavity or hypopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
These conditions may present with a range of symptoms, such as non-healing mouth ulcers, pain, bleeding and difficulty swallowing. On confirmation of diagnosis it may be possible to back-date clinical onset based on when relevant symptoms first began.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management generally involves surgery or radiotherapy +/- chemotherapy. Effectiveness of treatment varies with the type and stage or disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oral-cavity-oropharynx-and-hypopharynx-b034-140314041405141/rulebase-malignant-neoplasm-oral-cavity-and-oropharynx-and-hypopharynx/pipe-smoking
Regular oral use of smokeless tobacco
Current RMA Instruments
| Reasonable Hypothesis | 65 of 2021 |
| Balance of Probabilities | 66 of 2021 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 140.3,140.4,140.5,141,143,144,145,146,148
- ICD-10-AM Codes: C00-C06, C09-C10, C12-C13
Brief description
This SOP covers cancers of the mouth cavity (oral cavity), the back of the mouth cavity (oropharynx) and the area of the throat immediately below that (hypopharynx).
Confirming the diagnosis
Evidence on the histological type of tumour and the specific site of the tumour will be required, either from a biopsy or a surgical specimen. There are a number of cancer types involving these sites that are excluded from this SOP, including minor salivary gland cancers, which occur in the oral cavity but which are covered by a separate SOP. See excluded conditions list below.
The appropriate medical/dental specialist is an Oral surgeon or an Ear, Nose and Throat surgeon.
Sites covered by SOP
- alveolar ridge
- buccal (cheek) mucosa
- floor of mouth
- gingiva
- gums
- hard palate mucosa
- hypopharynx
- lingual tonsil coverings
- lips (mucosa of inside only)
- oropharynx
- palatine or faucial tonsil coverings
- post cricoid fossa
- pyriform fossa
- soft palate mucosa
- tongue mucosa
- tonsil fossa
- vallecula
Conditions excluded from SOP
- adenoid cystic carcinoma in the oral cavity (= minor salivary gland cancer)* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the larynx*
- malignant neoplasm of the lip epithelium* - non-melanotic malignant neoplasm of the skin SOP
- malignant neoplasm of the nasopharynx*
- malignant neoplasm of the minor salivary glands* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the oesophagus*
- malignant neoplasm of the salivary glands* (parotid, sublingual, submandibular)
- Hodgkin’s lymphoma* of the oral cavity, oropharynx or hypopharynx
- non-Hodgkin lymphoma* of the oral cavity, oropharynx or hypopharynx
- soft tissue sarcoma* of the oral cavity, oropharynx or hypopharynx
- carcinoid of the oral cavity, oropharynx or hypopharynx#
- secondary/metastatic cancer/carcinoma involving the oral cavity or hypopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
These conditions may present with a range of symptoms, such as non-healing mouth ulcers, pain, bleeding and difficulty swallowing. On confirmation of diagnosis it may be possible to back-date clinical onset based on when relevant symptoms first began.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management generally involves surgery or radiotherapy +/- chemotherapy. Effectiveness of treatment varies with the type and stage or disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oral-cavity-oropharynx-and-hypopharynx-b034-140314041405141/rulebase-malignant-neoplasm-oral-cavity-and-oropharynx-and-hypopharynx/regular-oral-use-smokeless-tobacco
Smoking tobacco products - material contribution
Current RMA Instruments
| Reasonable Hypothesis | 65 of 2021 |
| Balance of Probabilities | 66 of 2021 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 140.3,140.4,140.5,141,143,144,145,146,148
- ICD-10-AM Codes: C00-C06, C09-C10, C12-C13
Brief description
This SOP covers cancers of the mouth cavity (oral cavity), the back of the mouth cavity (oropharynx) and the area of the throat immediately below that (hypopharynx).
Confirming the diagnosis
Evidence on the histological type of tumour and the specific site of the tumour will be required, either from a biopsy or a surgical specimen. There are a number of cancer types involving these sites that are excluded from this SOP, including minor salivary gland cancers, which occur in the oral cavity but which are covered by a separate SOP. See excluded conditions list below.
The appropriate medical/dental specialist is an Oral surgeon or an Ear, Nose and Throat surgeon.
Sites covered by SOP
- alveolar ridge
- buccal (cheek) mucosa
- floor of mouth
- gingiva
- gums
- hard palate mucosa
- hypopharynx
- lingual tonsil coverings
- lips (mucosa of inside only)
- oropharynx
- palatine or faucial tonsil coverings
- post cricoid fossa
- pyriform fossa
- soft palate mucosa
- tongue mucosa
- tonsil fossa
- vallecula
Conditions excluded from SOP
- adenoid cystic carcinoma in the oral cavity (= minor salivary gland cancer)* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the larynx*
- malignant neoplasm of the lip epithelium* - non-melanotic malignant neoplasm of the skin SOP
- malignant neoplasm of the nasopharynx*
- malignant neoplasm of the minor salivary glands* - malignant neoplasm of the salivary gland SOP
- malignant neoplasm of the oesophagus*
- malignant neoplasm of the salivary glands* (parotid, sublingual, submandibular)
- Hodgkin’s lymphoma* of the oral cavity, oropharynx or hypopharynx
- non-Hodgkin lymphoma* of the oral cavity, oropharynx or hypopharynx
- soft tissue sarcoma* of the oral cavity, oropharynx or hypopharynx
- carcinoid of the oral cavity, oropharynx or hypopharynx#
- secondary/metastatic cancer/carcinoma involving the oral cavity or hypopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
These conditions may present with a range of symptoms, such as non-healing mouth ulcers, pain, bleeding and difficulty swallowing. On confirmation of diagnosis it may be possible to back-date clinical onset based on when relevant symptoms first began.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. Appropriate management generally involves surgery or radiotherapy +/- chemotherapy. Effectiveness of treatment varies with the type and stage or disease.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oral-cavity-oropharynx-and-hypopharynx-b034-140314041405141/rulebase-malignant-neoplasm-oral-cavity-and-oropharynx-and-hypopharynx/smoking-tobacco-products-material-contribution